MedTrace Logo

Dual-antiplatelet Therapy Strategies for Elective PCI in a Real-world Setting

NCT05559918 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1462

Last updated 2024-04-24

No results posted yet for this study

Summary

To assess the safety and efficacy of in-laboratory clopidogrel loading dose administration before ad-hoc PCI versus clopidogrel preloading treatment in patients planned for diagnostic angiography with optional ad-hoc PCI.

Conditions

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Ronak Delewi, MD, PhD · Amsterdam University Medical Center, location AMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2025-07-30
Completion
2025-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05559918 on ClinicalTrials.gov